Pure Global

"Leica" Bond Ready-to-Use Primary Antibody Lambda Light Chain (SHL53) (Non-Sterile) - Taiwan Registration 2d4738aa36f4f15e5b5fc59a23fd69c7

Access comprehensive regulatory information for "Leica" Bond Ready-to-Use Primary Antibody Lambda Light Chain (SHL53) (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 2d4738aa36f4f15e5b5fc59a23fd69c7 and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
2d4738aa36f4f15e5b5fc59a23fd69c7
Registration Details
Taiwan FDA Registration: 2d4738aa36f4f15e5b5fc59a23fd69c7
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Leica" Bond Ready-to-Use Primary Antibody Lambda Light Chain (SHL53) (Non-Sterile)
TW: โ€œ้Œธๅกโ€ ้‚ฆๅพทๅณ็”จๅž‹ไธ€็ดšๆŠ—้ซ”Lambda่ผ•้ˆ(ๆœชๆป…่Œ)
Risk Class 1
MD

Registration Details

2d4738aa36f4f15e5b5fc59a23fd69c7

Ministry of Health Medical Device Import No. 019577

DHA09401957701

Company Information

Product Details

Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.

B Hematology and pathology devices

B1860 Immunopathological histochemical reagents and kits

Imported from abroad

Dates and Status

Sep 06, 2018

Sep 06, 2028